P

Inventor

MCCOMBIE STUART W

US43 patents
⚠️ This page may combine multiple inventors who share the name “MCCOMBIE STUART W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

42 patents
US6066636AMay 23, 2000

Muscarinic antagonists

SCHERING CORP96 citations98
US5883096AMar 16, 1999

Muscarinic antagonists

SCHERING CORP164 citations98
US6689765B2Feb 10, 2004

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP71 citations97
US6391865B1May 21, 2002

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP94 citations97
US6037352AMar 14, 2000

Muscarinic antagonists

SCHERING CORP90 citations97
US5889006AMar 30, 1999

Muscarinic antagonists

SCHERING CORP123 citations97
US6387930B1May 14, 2002

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP76 citations96
US6294554B1Sep 25, 2001

Muscarinic antagonists

SCHERING CORP70 citations96
US6043255AMar 28, 2000

Muscarinic antagonists

SCHERING CORP50 citations95
US4876365AOct 24, 1989

Intermediate compounds for preparing penems and carbapenems

SCHERING CORP55 citations95
US6894063B2May 17, 2005

Substituted urea neuropeptide Y Y5 Receptor antagonists

SCHERING CORP24 citations93
US5318971AJun 7, 1994

3-Substituted-1-aryl-2(1H)-quinolones useful as anti-allergy and anti-inflammatory agents

SCHERING CORP27 citations93
US6602885B2Aug 5, 2003

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP21 citations92
US5179093AJan 12, 1993

Quinoline-diones

SCHERING CORP21 citations92
US6288068B1Sep 11, 2001

Muscarinic antagonists

SCHERING CORP22 citations91
US4973750ANov 27, 1990

Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols

SCHERING CORP40 citations91
US4582918AApr 15, 1986

Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols

SCHERING CORP45 citations91
US6946476B2Sep 20, 2005

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

SCHERING CORP16 citations83
US5064837ANov 12, 1991

3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions

SCHERING CORP17 citations82
US4237051ADec 2, 1980

Stereospecific production of 6- or 7-carbon-substituted-β-lactams

SCHERING CORP20 citations82
US4078139AMar 7, 1978

Process for deoxygenating secondary alcohols

SCHERING CORP25 citations82
US4435413AMar 6, 1984

(5R-6S,8R)-6-(1-Hydroxyethyl)-2-(2-glycylaminoethylthio)-penem-3-carboxylic acid

SCHERING CORP7 citations74
US4411906AOct 25, 1983

(5R,6S,8R)-6-(1-Hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylates

SCHERING CORP6 citations74
US4314942AFeb 9, 1982

Deprotection of allylic esters, carbonates and carbamates catalyzed by palladium compounds

SCHERING CORP12 citations74
US4053591AOct 11, 1977

5-deoxy-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, method for their use as antibacterial agents and compositions useful therefor

SCHERING CORP10 citations74
US7384944B2Jun 10, 2008

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP6 citations73
US6982267B2Jan 3, 2006

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

SCHERING CORP9 citations73
US6498168B2Dec 24, 2002

Muscarinic antagonists

SCHERING CORP5 citations73
US4283531AAug 11, 1981

Synthesis of β-lactams having a substituted hydroxymethylene group at the position α to the lactam carbonyl group

SCHERING CORP7 citations72
US4272439AJun 9, 1981

6-(Substituted-hydroxymethylene penams)

SCHERING CORP12 citations72
US4882429ANov 21, 1989

Stereospecific preparation of (3S,4R,5R)-3-(1-hydroxyethyl)-4-benzoyloxy-azeridinones from L-(-)-theonine

SCHERING CORP9 citations68
US4683226AJul 28, 1987

6-hydroxyalkyl-2-(substituted-thio)penem-3-carboxylic acids

SCHERING CORP2 citations63
US4504485AMar 12, 1985

5R,6S,8R-6-(1-Hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylic acid

SCHERING CORP2 citations63
US4456609AJun 26, 1984

(5R, 6S, 8R-6-(1-Hydroxyethyl)-2-(2-[methylaminocarbonyl]-ethylthio)-penem-3-carboxylic acid

SCHERING CORP5 citations63
US4443463AApr 17, 1984

(5R,6S,8R)-6-(1-Hydroxyethyl)-2-(hydroxyalkylthio)-penem-3-carboxylates

SCHERING CORP4 citations63
US4423055ADec 27, 1983

6-Substituted-hydrocarbon-2-(substituted-thio)penem-3-carboxylic acids

SCHERING CORP5 citations63
US7309704B2Dec 18, 2007

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

SCHERING CORP2 citations62
US4677214AJun 30, 1987

Intermediates for preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols

SCHERING CORP4 citations61
US6451797B1Sep 17, 2002

Muscarinic antagonists

SCHERING CORP1 citations52
US4762827AAug 9, 1988

(5R,6S,8R)-6-(1-hydroxyethyl)-2-(3R-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid

SCHERING CORP0 citations52
US7705019B2Apr 27, 2010

Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors

SCHERING CORP0 citations34
US7659275B2Feb 9, 2010

Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors

SCHERING CORP0 citations33

BAROUDY BAHIGE M

1 patent